Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Zhang, Ran  [Clear All Filters]
2024
Li Q, Lin X, Zhang R, Wang J, Wang J, Zhang C, Wang S, Wu X. Application of Slice Culture System for Successional Dental Lamina in Diphyodont Mammals. Stem Cells Dev. 2024.
Zhao H, Wang S, Yang R, Yang D, Zhao Y, Kuang J, Chen L, Zhang R, Hu H. Side chain of confined xylan affects cellulose integrity leading to bending stem with reduced mechanical strength in ornamental plants. Carbohydr Polym. 2024;329:121787.
2023
Wu K, Guan L-N, Zhang J-Y, Zhang R, Bian Z-L, Wang C, Wan D-M, Cao W-J. [Analysis of Clinical Features and Risk Factors for Oral Ulcers and Bloodstream Infection in Patients with Hematopoietic Stem Cell Transplantation]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023;31(3):866-870.
Li D, Luo L, Guo L, Wu C, Zhang R, Peng Y, Wu M, Kuang J, Li Y, Zhang Y, et al. c-Jun as a one-way valve at the naive to primed interface. Cell Biosci. 2023;13(1):191.
Zhong H, Zhang R, Li G, Huang P, Zhang Y, Zhu J, Kuang J, Hutchins AP, Qin D, Zhu P, et al. c-JUN is a barrier in hESC to cardiomyocyte transition. Life Sci Alliance. 2023;6(11).
Li L, Zhang R, Cao W, Bian Z, Qin Y, Guo R, Zhang S, Peng Y, Wan D, Ma W. Comparative analysis of hypomethylating agents as maintenance therapy after allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia. Leuk Lymphoma. 2023:1-10.
Mar D, Babenko IM, Zhang R, Noble WStafford, Denisenko O, Vaisar T, Bomsztyk K. A high throughput PIXUL-Matrix-based toolbox to profile frozen and FFPE tissues multiomes. Lab Invest. 2023:100282.
Zhang R, Xin R, Dou L-P, Jing Y. [Research Progress in Treatment of Chronic Lymphocytic Leukemia --Review]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023;31(6):1910-1915.
Hu Y, Zhang R, Zhang S, Ji Y, Zhou Q, Leng L, Meng F, Gong F, Lu G, Lin G, et al. Transcriptomic profiles reveal the characteristics of oocytes and cumulus cells at GV, MI, and MII in follicles before ovulation. J Ovarian Res. 2023;16(1):225.
Liu Y, Li Y, Zhang R, Yu Z, Jing Y. Venetoclax combined with hypomethylating agents and the CAG regimen in relapsed/refractory AML: a single-center clinical trial. Front Immunol. 2023;14:1269163.
2022
Zhang Y, Liu C, Zhang R, Shi Y, Li X, Yu J, Wan D, Xie X. Impact of treatments before allogeneic hematopoietic stem cell transplantation in patients with higher-risk myelodysplastic syndrome. Leuk Res. 2022;124:106997.
Xi C, Sun J, Xu X, Wu Y, Kou X, Zhao Y, Shen J, Dong Y, Chen K, Su Z, et al. Mettl14-driven senescence-associated secretory phenotype facilitates somatic cell reprogramming. Stem Cell Reports. 2022;17(8):1799-1809.
2018
Zhang R, Lu X, Wang H, You Y, Zhong Z, Zang S, Zhang C, Shi W, Li J, Wu Q, et al. IDA-intensified hematopoietic cell transplantation improves relapse and survival of high-risk acute leukemia patients with minimal residual disease. Biol Blood Marrow Transplant. 2018.
2016
Fang J, Zhang R, Wang H, Hong M, Wu Q, Nie D, You Y, Zhong Z, Li W, Hu Y, et al. Idarubicin-intensified BUCY2 conditioning regimen improved survival in high-risk acute myeloid, but not lymphocytic leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: A retrospective comparative study. Leuk Res. 2016;46:61-68.
Zhou X, Wang J, Sun H, Qi Y, Xu W, Luo D, Jin X, Li C, Chen W, Lin Z, et al. MicroRNA-99a regulates early chondrogenic differentiation of rat mesenchymal stem cells by targeting the BMPR2 gene. Cell Tissue Res. 2016.
2014
Wang Y, Li C, Cheng K, Zhang R, Narsinh K, Li S, Li X, Qin X, Zhang R, Li C, et al. Activation of Liver X receptor improves viability of adipose-derived mesenchymal stem cells (AD-MSCs) to attenuate myocardial ischemia injury through TLR4/NF-κB and Keap-1/Nrf2 signaling pathways. Antioxid Redox Signal. 2014.